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A 78-year-old man presented with swelling of para-aortic and left iliac lymph nodes (LNs). He had 
undergone left high orchiectomy 10 years ago. He was diagnosed with stage I seminoma, and was managed 
with active surveillance. Eight years later, the follow-up computed tomography (CT) revealed para-aortic 
LN swelling, but the patient refused further treatment. He complained of left lower extremity edema 10 
years after orchiectomy. CT showed enlargement of both LNs, especially, diameter ofleft iliac lymph nodes 
was up to 9 cm. He was referred to our hospital. LDH was slightly increased to 261 IU/1, but α－ 
fetoprotein, and totョland free beta human chorionic gonadotropin were within normal limits. Results of 
pathological review of the testicular tumor was also seminoma. The treatment with etoposide and cisplatin 
(EP) was started under the diagnosis oflate relapse of悶 ninoma. However, CT after 1 course ofEP showed 
no shrinkage of LN metastases. At this time, soluble interleukin-2 receptor (sIL-2R) was elevated up to 
5,090 U/ml (normal range: 613 U/ml). Needle biopsy from pel札cLN was pe巾 rmedon suspicion of 
metachronous malignant lymphoma. The pathological diagnosis was mantle cel lymphoma. The patient 
was transferred to the department of hematology, and treated successfully wi由rituximaband bendamustine. 
When LN swelling is seen after long-term active surveillance, there is a possibility oflate relapse. However, 
metachronous malignant lymphoma also should be considered in an elderly patient. 
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蕩に対して高位精巣摘除術施行. LDH, hCG, AFP 
は術前より陰性であった．腫蕩径は 2.2cmで病理診





















Fig. 1. A, B) CT in June, 2015. A small paraaortic lymph node (LN) was陀vealed(A, arro吋， there 
was no LN swelling in the left iliac region. C, D) CT in August, 2016. 14 months later, size 
and number of代troperitonealLN metastases (C, arr州 increased. The left ilac LN 
metastasis newly developed (D, arrow). E，町CTinJune, 2017. Ten months later, size and 
number of retroperitoneal LN metastases (E, arrow) further increased. The size of the left ilac 
LN metastasis markedly increased (F, arrow). G, H) CT after one course of etoposide + 
cisplatin (EP). Neither retroperitoneal LN nor left iliac LN metastases responded to EP therapy 
(G, H, arrows). 




上限 211IU/1)，インタクト hCG0. 6 mIU/ml （正常
上限0.5mIU/ml）が正常上限を僅かに超えるのみで＼
トータル hCG，フリー PhCGは検出限界以下であっ














(A) HE stain×200 


















組織型セミ ノー マであった．しかし， EP療法への反
応性が極端に不良であること リンパ節腫大が発症し
てからの経過が長いことに加え，追加測定した可溶性
(B) CDS （×200) 
(D) Cyclin-D1 （×200) 
Fig. 2. HE stain showed that diffuse proliferation of small lymphoid cels with high nucleocytoplasmic ratio (A) 
(HE stain ×200). lmmunohistochemical staining showed that tumor cels were positive for CD5, CD20 
and Cyclin-D I，但）CD5 （×200), (C) CD20 （×200), (D) Cyclin-Dl （×200). 
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インターロイキン 2受容体（solubleinterleukin-2 recep-





牲に増殖しており，免疫染色でCDS( + ),CD20 






rituximab + bendamustine (RB療法）を開始した RB


































































ことが知られており， ECOGperformance status, LDH 
値，白血球数から予後評価（Mantlecel International 








LDH (Iu;l) イン（mタIクU/トml~CG フリ（n;;;;ffG
正常値 1 l例 20例 16例
高値 26例 17例 21例
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